UnitedHealth's Stealth Sales Drive Earnings Success
UnitedHealth boosted its earnings by $3.3 billion through discreet asset sales to private equity firms, which helped it meet Wall Street estimates despite rising costs and regulatory scrutiny. These deals, some with buy-back options, were not widely publicized and raised questions about the quality and transparency of the company's earnings reporting.